Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of the National Cancer Institute
|
May 14, 2009
Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis
Xiangsheng Zuo, Zhanglong Peng, Micheline J Moussalli, et al.
Gastroenterology
|
January 29, 1999
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group
R Sobesky, P Mathurin, F Charlotte, et al.
Journal of Viral Hepatitis
|
February 16, 2006
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
C d'Arondel, M Munteanu, J Moussalli, et al.
Transplantation
|
October 1, 1991
Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months
J F Cadranel, P Grippon, F Lunel, et al.
Gastroenterologie Clinique Et Biologique
|
July 31, 2009
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials
T Poynard, J Massard, M Rudler, et al.
Acta Gastro-Enterologica Belgica
|
January 29, 1999
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie
T Poynard, J Moussalli, V Ratziu, et al.
Journal of Hepatology
|
July 29, 1999
A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France
S Pol, P Couzigou, M Bourlière, et al.
Journal of Viral Hepatitis
|
June 26, 2002
Fatigue in patients with chronic hepatitis C
T Poynard, P Cacoub, V Ratziu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 26, 2015
15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway
Fei Mao, Min Xu, Xiangsheng Zuo, et al.
Gastroenterologie Clinique Et Biologique
|
December 17, 2008
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update
T Poynard, M Muntenau, R Morra, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of the National Cancer Institute
|
May 14, 2009
Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis
Xiangsheng Zuo, Zhanglong Peng, Micheline J Moussalli, et al.
Gastroenterology
|
January 29, 1999
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group
R Sobesky, P Mathurin, F Charlotte, et al.
Journal of Viral Hepatitis
|
February 16, 2006
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
C d'Arondel, M Munteanu, J Moussalli, et al.
Transplantation
|
October 1, 1991
Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months
J F Cadranel, P Grippon, F Lunel, et al.
Gastroenterologie Clinique Et Biologique
|
July 31, 2009
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials
T Poynard, J Massard, M Rudler, et al.
Acta Gastro-Enterologica Belgica
|
January 29, 1999
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie
T Poynard, J Moussalli, V Ratziu, et al.
Journal of Hepatology
|
July 29, 1999
A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France
S Pol, P Couzigou, M Bourlière, et al.
Journal of Viral Hepatitis
|
June 26, 2002
Fatigue in patients with chronic hepatitis C
T Poynard, P Cacoub, V Ratziu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 26, 2015
15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway
Fei Mao, Min Xu, Xiangsheng Zuo, et al.
Gastroenterologie Clinique Et Biologique
|
December 17, 2008
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update
T Poynard, M Muntenau, R Morra, et al.
Page
of 4